Verona Pharma PLC Holding(s) in Company (8834F)
August 01 2016 - 10:57AM
UK Regulatory
TIDMVRP
RNS Number : 8834F
Verona Pharma PLC
01 August 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Verona Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ -----------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
------------------------------------------------------- ----------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------- ----------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------- ----------------------------
An event changing the breakdown of voting rights
------------------------------------------------------- ----------------------------
Other (please
specify):
----------------------------------------------------- ----------------------------
3. Full name of person(s) Growth Equity Opportunities
subject to the IV, LLC
notification obligation:
(iii)
------------------------------------------------------ -----------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
------------------------------------------------------ -----------------------------
5. Date of the transaction July 29, 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ -----------------------------
6. Date on which issuer July 29, 2016
notified:
------------------------------------------------------ -----------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 8%
------------------------------------------------------ -----------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- -----------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- --------------- --------------- -------------- ---------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- -------------- -------------- ------------ ------------ -----------
Ordinary
Shares
GB00B06GSH43 221,203,271 221,203,271 8.6%
--------------- --------------- -------------- -------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------- ------------------------------- ------------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- ---------------- ------------------------------ -----------------------
Nominal Delta
--------------- ------------- ------------- ---------------- ------------------------------ ------------ ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- ---------------------------------------------------------------------
221,203,271 8.6%
------------------------------------------------- ---------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------------------
Growth Equity Opportunities IV, LLC is a limited liability
company formed in the State of Delaware, United States
New Enterprise Associates 15, L.P., a limited partnership
formed in the State of Delaware, is its sole member
NEA Partners 15, L.P., a limited partnership formed
in the State of Delaware, is its general partner
NEA 15 GP, LLC, a limited liability company formed in
the State of Delaware, is its general partner
Proxy Voting:
--------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- ----------------------------------
11. Number of voting rights proxy
holder will cease to hold:
-------------------------------------------------------------- ----------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
-------------------------------------------------------------- ----------------------------------
13. Additional information: Figures are based on a total
number of 2,565,719,826 Ordinary
Shares outstanding, as per
the Company's Result of General
Meeting announcement of 22
July 2016, along with the
Warrant Instrument shares
reported in 8.B.
-------------------------------------------------------------- ----------------------------------
14. Contact name: Louis Citron, New Enterprise
Associates
-------------------------------------------------------------- ----------------------------------
15. Contact telephone number: +1 (410) 842-4000
-------------------------------------------------------------- ----------------------------------
HOLUGUUARUPQGCG
(END) Dow Jones Newswires
August 01, 2016 10:57 ET (14:57 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
